Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amber L. Zeeman"'
Autor:
Mirjam C. Boelens, Micha Nethe, Sjoerd Klarenbeek, Julian R. de Ruiter, Eva Schut, Nicola Bonzanni, Amber L. Zeeman, Ellen Wientjens, Eline van der Burg, Lodewyk Wessels, Renée van Amerongen, Jos Jonkers
Publikováno v:
Cell Reports, Vol 16, Iss 8, Pp 2087-2101 (2016)
Invasive lobular carcinoma (ILC) is an aggressive breast cancer subtype with poor response to chemotherapy. Besides loss of E-cadherin, a hallmark of ILC, genetic inactivation of PTEN is frequently observed in patients. Through concomitant Cre-mediat
Externí odkaz:
https://doaj.org/article/d60d88237f8443e6ad63bec0763199eb
Autor:
Bernadette Jeremiasse, Ravian L van Ineveld, Veerle Bok, Michiel Kleinnijenhuis, Sam de Blank, Maria Alieva, Hannah R Johnson, Esmée J van Vliet, Amber L Zeeman, Lianne M Wellens, Gerard Llibre-Palomar, Mario Barrera Román, Alessia Di Maggio, Johanna F Dekkers, Sabrina Oliveira, Alexander L Vahrmeijer, Jan J Molenaar, Marc HWA Wijnen, Alida FW van der Steeg, Ellen J Wehrens, Anne C Rios
Publikováno v:
EMBO Molecular Medicine, Vol 16, Iss 7, Pp 1495-1514 (2024)
Abstract Achieving complete tumor resection is challenging and can be improved by real-time fluorescence-guided surgery with molecular-targeted probes. However, pre-clinical identification and validation of probes presents a lengthy process that is t
Externí odkaz:
https://doaj.org/article/59beb6ac34b24791970db0bb11a508eb
Autor:
Johanna F. Dekkers, Maria Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Peter Brazda, Inez Johanna, Angelo D. Meringa, Heggert G. Rebel, Maj-Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary Millen, Trudy Straetemans, Mara J. T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C. R. Ariese, Hannah R. Johnson, Ravian L. van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar-Ephraim, Kai Kretzschmar, Alexander M. M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyen, Anne C. Rios
Publikováno v:
Nature Biotechnology. Nature Publishing Group
Extending the success of cellular immunotherapies against blood cancers to the realm of solid tumors will require improved in vitro models that reveal therapeutic modes of action at the molecular level. Here we describe a system, called BEHAV3D, deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f13e816394f157842a7bd4b7c168dfc
https://hdl.handle.net/20.500.11755/61e7d6c0-d595-417b-8a49-c504fbe82e8e
https://hdl.handle.net/20.500.11755/61e7d6c0-d595-417b-8a49-c504fbe82e8e